Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Blocking LPA-dependent signaling increases ovarian cancer cell death in response to chemotherapy.

Rogers LC, Davis RR, Said N, Hollis T, Daniel LW.

Redox Biol. 2018 May;15:380-386. doi: 10.1016/j.redox.2018.01.002. Epub 2018 Jan 4.

2.

The SAMHD1 dNTP Triphosphohydrolase Is Controlled by a Redox Switch.

Mauney CH, Rogers LC, Harris RS, Daniel LW, Devarie-Baez NO, Wu H, Furdui CM, Poole LB, Perrino FW, Hollis T.

Antioxid Redox Signal. 2017 Dec 1;27(16):1317-1331. doi: 10.1089/ars.2016.6888. Epub 2017 Apr 18.

PMID:
28398823
3.

Endosomal H2O2 production leads to localized cysteine sulfenic acid formation on proteins during lysophosphatidic acid-mediated cell signaling.

Klomsiri C, Rogers LC, Soito L, McCauley AK, King SB, Nelson KJ, Poole LB, Daniel LW.

Free Radic Biol Med. 2014 Jun;71:49-60. doi: 10.1016/j.freeradbiomed.2014.03.017. Epub 2014 Mar 21.

4.

Reactive oxygen species mediate lysophosphatidic acid induced signaling in ovarian cancer cells.

Saunders JA, Rogers LC, Klomsiri C, Poole LB, Daniel LW.

Free Radic Biol Med. 2010 Dec 15;49(12):2058-67. doi: 10.1016/j.freeradbiomed.2010.10.663. Epub 2010 Oct 8.

5.

Use of dimedone-based chemical probes for sulfenic acid detection methods to visualize and identify labeled proteins.

Nelson KJ, Klomsiri C, Codreanu SG, Soito L, Liebler DC, Rogers LC, Daniel LW, Poole LB.

Methods Enzymol. 2010;473:95-115. doi: 10.1016/S0076-6879(10)73004-4. Review.

6.

Novel translocation responses of cytosolic phospholipase A2alpha fluorescent proteins.

Wooten RE, Willingham MC, Daniel LW, Leslie CC, Rogers LC, Sergeant S, O'Flaherty JT.

Biochim Biophys Acta. 2008 Aug;1783(8):1544-50. doi: 10.1016/j.bbamcr.2008.03.008. Epub 2008 Mar 21.

7.

Fluorescent and affinity-based tools to detect cysteine sulfenic acid formation in proteins.

Poole LB, Klomsiri C, Knaggs SA, Furdui CM, Nelson KJ, Thomas MJ, Fetrow JS, Daniel LW, King SB.

Bioconjug Chem. 2007 Nov-Dec;18(6):2004-17. Epub 2007 Nov 21.

8.

The requirement of reversible cysteine sulfenic acid formation for T cell activation and function.

Michalek RD, Nelson KJ, Holbrook BC, Yi JS, Stridiron D, Daniel LW, Fetrow JS, King SB, Poole LB, Grayson JM.

J Immunol. 2007 Nov 15;179(10):6456-67.

9.

Omega-3 fatty acids and cancer risk.

Chen YQ, Berquin IM, Daniel LW, Edwards IJ, O'Flaherty JT, Thomas MJ, Tooze JA, Wykle B.

JAMA. 2006 Jul 19;296(3):282; author reply 282. No abstract available.

PMID:
16849660
10.

Algebraic dependency models of protein signal transduction networks from time-series data.

Allen EE, Fetrow JS, Daniel LW, Thomas SJ, John DJ.

J Theor Biol. 2006 Jan 21;238(2):317-30. Epub 2005 Jul 5.

PMID:
16002094
11.

Differential effects of delivery of omega-3 fatty acids to human cancer cells by low-density lipoproteins versus albumin.

Edwards IJ, Berquin IM, Sun H, O'flaherty JT, Daniel LW, Thomas MJ, Rudel LL, Wykle RL, Chen YQ.

Clin Cancer Res. 2004 Dec 15;10(24):8275-83.

12.
13.

5(S)-Hydroxy-6,8,11,14-E,Z,Z,Z-eicosatetraenoate stimulates PC3 cell signaling and growth by a receptor-dependent mechanism.

O'Flaherty JT, Rogers LC, Chadwell BA, Owen JS, Rao A, Cramer SD, Daniel LW.

Cancer Res. 2002 Dec 1;62(23):6817-9.

14.

Regulation of platelet-activating factor synthesis in human neutrophils by MAP kinases.

Baker PR, Owen JS, Nixon AB, Thomas L, Wooten R, Daniel LW, O'Flaherty JT, Wykle RL.

Biochim Biophys Acta. 2002 Oct 21;1592(2):175-84.

16.

Protein kinases C translocation responses to low concentrations of arachidonic acid.

O'Flaherty JT, Chadwell BA, Kearns MW, Sergeant S, Daniel LW.

J Biol Chem. 2001 Jul 6;276(27):24743-50. Epub 2001 Apr 27.

17.

Phospholipase D, tumor promoters, proliferation and prostaglandins.

Daniel LW, Sciorra VA, Ghosh S.

Biochim Biophys Acta. 1999 Jul 30;1439(2):265-76. Review.

PMID:
10425400
18.
20.

Comparison of alkylacylglycerol vs. diacylglycerol as activators of mitogen-activated protein kinase and cytosolic phospholipase A2 in human neutrophil priming.

Nixon AB, Seeds MC, Bass DA, Smitherman PK, O'Flaherty JT, Daniel LW, Wykle RL.

Biochim Biophys Acta. 1997 Aug 16;1347(2-3):219-30.

PMID:
9295167
22.

5-Oxo-eicosanoids and hematopoietic cytokines cooperate in stimulating neutrophil function and the mitogen-activated protein kinase pathway.

O'Flaherty JT, Kuroki M, Nixon AB, Wijkander J, Yee E, Lee SL, Smitherman PK, Wykle RL, Daniel LW.

J Biol Chem. 1996 Jul 26;271(30):17821-8.

23.

5-Oxo-eicosatetraenoate is a broadly active, eosinophil-selective stimulus for human granulocytes.

O'Flaherty JT, Kuroki M, Nixon AB, Wijkander J, Yee E, Lee SL, Smitherman PK, Wykle RL, Daniel LW.

J Immunol. 1996 Jul 1;157(1):336-42.

PMID:
8683135
25.

Activation of 85 kDa PLA2 by eicosanoids in human neutrophils and eosinophils.

Wykle RL, Wijkander J, Nixon AB, Daniel LW, O'Flaherty JT.

Adv Exp Med Biol. 1996;416:327-31. Review. No abstract available.

PMID:
9131168
26.

Protein kinase C inhibition by ET-18-OCH3 and related analogs. A target for cancer chemotherapy.

Pauig SB, Daniel LW.

Adv Exp Med Biol. 1996;416:173-80. Review. No abstract available.

PMID:
9131145
27.
28.
29.

Phospholipase D hydrolyzes ether- and ester-linked glycerophospholipids by different pathways in MDCK cells.

Huang C, Wykle RL, Daniel LW.

Biochem Biophys Res Commun. 1995 Aug 24;213(3):950-7.

PMID:
7654259
30.

1-beta-D-Arabinofuranosylcytosine stimulates ceramide and diglyceride formation in HL-60 cells.

Strum JC, Small GW, Pauig SB, Daniel LW.

J Biol Chem. 1994 Jun 3;269(22):15493-7.

31.

Relationship of cell survival, drug dose, and drug uptake after 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine treatment.

Fujiwara K, Daniel LW, Modest EJ, Wallen CA.

Cancer Chemother Pharmacol. 1994;34(6):472-6.

PMID:
7923557
33.

Phospholipase D hydrolysis of choline phosphoglycerides is selective for the alkyl-linked subclass of Madin-Darby canine kidney cells.

Daniel LW, Huang C, Strum JC, Smitherman PK, Greene D, Wykle RL.

J Biol Chem. 1993 Oct 15;268(29):21519-26.

34.

Evaluation of phospholipase C and D activity in stimulated human neutrophils using a phosphono analog of choline phosphoglyceride.

Strum JC, Nixon AB, Daniel LW, Wykle RL.

Biochim Biophys Acta. 1993 Jul 21;1169(1):25-9.

PMID:
8334146
35.

A facile synthesis of 1-O-alkyl-2-(R)-hydroxypropane-3-phosphonocholine (lyso-phosphono-platelet activating factor).

Schmitt JD, Nixon AB, Emilsson A, Daniel LW, Wykle RL.

Chem Phys Lipids. 1992 Oct;62(3):263-8.

PMID:
1468125
36.
38.

Novel membrane-interactive ether lipid analogs that inhibit infectious HIV-1 production and induce defective virus formation.

Kucera LS, Iyer N, Leake E, Raben A, Modest EJ, Daniel LW, Piantadosi C.

AIDS Res Hum Retroviruses. 1990 Apr;6(4):491-501.

PMID:
1692729
39.

Synthesis and biological activity of novel quaternary ammonium derivatives of alkylglycerols as potent inhibitors of protein kinase C.

Marasco CJ Jr, Piantadosi C, Meyer KL, Morris-Natschke S, Ishaq KS, Small GW, Daniel LW.

J Med Chem. 1990 Mar;33(3):985-92.

PMID:
2308148
40.
41.

Synthesis and biological evaluation of ether-linked derivatives of phosphatidylinositol.

Ishaq KS, Capobianco M, Piantadosi C, Noseda A, Daniel LW, Modest EJ.

Pharm Res. 1989 Mar;6(3):216-24.

PMID:
2726677
42.

Choline-linked phosphoglycerides. A source of phosphatidic acid and diglycerides in stimulated neutrophils.

Agwu DE, McPhail LC, Chabot MC, Daniel LW, Wykle RL, McCall CE.

J Biol Chem. 1989 Jan 25;264(3):1405-13.

43.

Stimulation of arachidonic acid release and prostaglandin synthesis by bryostatin 1.

Parker J, Waite M, Pettit GR, Daniel LW.

Carcinogenesis. 1988 Aug;9(8):1471-4.

PMID:
3135956
44.

Synthesis and evaluation of neoplastic cell growth inhibition of 1-N-alkylamide analogues of glycero-3-phosphocholine.

Marx MH, Piantadosi C, Noseda A, Daniel LW, Modest EJ.

J Med Chem. 1988 Apr;31(4):858-63.

PMID:
3162534
45.

Alkyl-linked diglycerides inhibit protein kinase C activation by diacylglycerols.

Daniel LW, Small GW, Schmitt JD, Marasco CJ, Ishaq K, Piantadosi C.

Biochem Biophys Res Commun. 1988 Feb 29;151(1):291-7.

PMID:
3348778
46.

Phospholipase activity of bacterial toxins.

Daniel LW, King L, Kennedy M.

Methods Enzymol. 1988;165:298-301. No abstract available.

PMID:
3068488
47.
48.

Phospholipase D activity of Vibrio damsela cytolysin and its interaction with sheep erythrocytes.

Kreger AS, Bernheimer AW, Etkin LA, Daniel LW.

Infect Immun. 1987 Dec;55(12):3209-12.

49.

Ether lipids inhibit the effects of phorbol diester tumor promoters.

Daniel LW, Etkin LA, Morrison BT, Parker J, Morris-Natschke S, Surles JR, Piantadosi C.

Lipids. 1987 Nov;22(11):851-5.

PMID:
3444377
50.

The degradation of platelet-activating factor and related lipids: susceptibility to phospholipases C and D.

Wilcox RW, Wykle RL, Schmitt JD, Daniel LW.

Lipids. 1987 Nov;22(11):800-7.

PMID:
3444369

Supplemental Content

Loading ...
Support Center